Ongoing increasing temporal and geographical trends of the incidence of extended-spectrum beta-lactamase-producing Enterobacteriaceae infections in France, 2009 to 2013
Authors:
- National Early Warning, Investigation and Surveillance of Healthcare-Associated Infections Network (RAISIN)/multidrug resistance study groupNGNational Early Warning, Investigation and Surveillance of Healthcare-Associated Infections Network (RAISIN)/multidrug resistance study group
Open Access
- 10 September 2015
- journal article
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 20 (36) , 30014
Abstract
Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) are a major focus of multidrug-resistant organisms (MRO) surveillance programmes in France. To describe the temporal and geographical trends of these pathogens, we conducted an epidemiological study based on data extracted from the nationwide MRO surveillance network from 2009 to 2013. During this time, the incidence of ESBL-E infections in French hospitals increased by 73%, from 0.35 to 0.60 per 1,000 patient days (PD) (p < 0.001) and ESBL-E bacteraemia by 77%, from 0.03 to 0.05 per 1,000 PD (p < 0.001). The incidence of ESBL-E infections was higher in intensive-care units (1.62 to 2.44 per 1,000 PD (p < 0.001)) than in recovery and long-term care facilities (0.20 to 0.31 per 1,000 PD (p < 0.001)). Escherichia coli was the most frequent extended-spectrum beta-lactamase-producing (ESBL) pathogen, representing 59% (26,238/44,425) of all ESBL isolates, followed by Klebsiella pneumoniae (20%; 8,856/44,425) in 2013. The most frequent infection was urinary tract infection, for all species. The incidence of ESBL-E varied by region but showed an upward trend overall. Reinforcement of control measures for halting the spread of such MRO is crucial.Keywords
This publication has 21 references indexed in Scilit:
- Changing epidemiology of infections due to extended spectrum beta-lactamase producing bacteriaAntimicrobial Resistance & Infection Control, 2014
- Four-year epidemiological study of extended-spectrum β-lactamase-producing Enterobacteriaceae in a French teaching hospitalClinical Microbiology and Infection, 2014
- Risk factors for developing ESBL E. coli: can clinicians predict infection in patients with prior colonization?Journal of Hospital Infection, 2013
- Duration of colonization by extended-spectrum β-lactamase-producing Enterobacteriaceae after hospital dischargeAmerican Journal of Infection Control, 2013
- Efficacy of Admission Screening for Extended-Spectrum Beta-Lactamase Producing EnterobacteriaceaePLOS ONE, 2013
- Burden of Bloodstream Infection Caused by Extended-Spectrum β-Lactamase–Producing Enterobacteriaceae Determined Using Multistate Modeling at a Swiss University Hospital and a Nationwide Predictive ModelInfection Control & Hospital Epidemiology, 2013
- National multidrug-resistant bacteria (MDRB) surveillance in France through the RAISIN network: a 9 year experienceJournal of Antimicrobial Chemotherapy, 2012
- Curbing Methicillin-Resistant Staphylococcus aureus in 38 French Hospitals Through a 15-Year Institutional Control ProgramArchives of internal medicine (1960), 2010
- Dramatic Increase in Prevalence of Fecal Carriage of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae during Nonoutbreak Situations in SpainJournal of Clinical Microbiology, 2004
- Risk Factors for the Development of Extended-Spectrum Beta-Lactamase-Producing Bacteria in Nonhospitalized PatientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004